Natalia Perekhvatova

О себе

Natalia Perekhvatova is the CEO of Mitotech S.A., a Luxembourg-based clinical-stage biotechnology company developing mitochondria-targeted drugs for age-related disorders, especially in ophthalmology. Mitotech says she joined as Chief Financial Officer in 2010 and helped lead the company from drug discovery into clinical-stage development. Before Mitotech, she held senior roles at Citigroup and Amadeus and earned an MBA from INSEAD.

Области интересов